Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) — Announcement

1 Announcement Neutral 📄 PDF

📢 Key Event
Jagsonpal to acquire 85% stake in Aequitas Healthcare

🔮 What's Next
concluded by 15th July, 2026

💡 Investor Takeaway
The acquisition provides Jagsonpal with a ready platform to enter the hospital segment, which now contributes ~10% of pharma industry sales and is growing faster.

Jagsonpal Pharmaceuticals announced it will acquire an 85% stake in Aequitas Healthcare Private Limited for Rs. 20.8 crores, marking its strategic entry into the hospital segment and expanding its presence in India's growing healthcare ecosystem.

2 Announcement Neutral 📄 PDF

📢 Key Event
Jagsonpal to acquire 85% stake in Aequitas Healthcare for INR 20.8 crores

🔮 What's Next
15th July 2026

💡 Investor Takeaway
This acquisition gives Jagsonpal direct access to hospital networks, accelerating its shift beyond retail into high-growth healthcare channels.

Jagsonpal Pharmaceuticals announced it will acquire an 85% stake in Aequitas Healthcare Private Limited for INR 20.8 crores in cash, marking its strategic entry into the hospital distribution segment and expanding its presence in India's growing healthcare ecosystem.

📊 Stock Analysis — JAGSNPHARM ✨ Ask AI About This